Collaborative Trajectory Analysis Project
Business Services · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1 Broadway, Cambridge, Massachusetts, 02...Website
www.ctap-duchenne.orgRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Collaborative Trajectory Analysis Project
cTAP focuses on enhancing clinical trials for Duchenne Muscular Dystrophy by leveraging data science to facilitate faster learning and smarter drug development. The organization aims to unlock the potential of patient data through strategic, collaborative, and non-competitive research, fostering cross-stakeholder collaboration. Their mission is to support rare neuromuscular communities in making sense of patient data for more effective clinical research. cTAP partners with patient organizations, scientific leaders, researchers, and industry to accelerate research for the global Duchenne community.Explore more
Collaborative Trajectory Analysis Project Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Collaborative Trajectory Analysis Project your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Collaborative Trajectory Analysis Project launches new products
Check if Collaborative Trajectory Analysis Project has recently received funding, and reach out quickly before it becomes old news!
Collaborative Trajectory Analysis Project, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Collaborative Trajectory Analysis Project has new funding data
Check out if Collaborative Trajectory Analysis Project is spiking on competitors!
Earning: See what the market has to say on Collaborative Trajectory Analysis Project recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Collaborative Trajectory Analysis Project
Click to see if Collaborative Trajectory Analysis Project had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Collaborative Trajectory Analysis Project
Compare insights from companies similar to Collaborative Trajectory Analysis Project, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Collaborative Trajectory Analysis Project is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Collaborative Trajectory Analysis Project is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Collaborative Trajectory Analysis Project.
Collaborative Trajectory Analysis Project Tech Stack
A closer look at the technologies used by Collaborative Trajectory Analysis Project
See more technologies
Collaborative Trajectory Analysis Project News & Media
cTAP Publishes Comprehensive Analysis of the North Star Ambulatory Assessment (NSAA), a Newly Adopted Primary Outcome Measure in Clinical Trials of Patients with Duchenne Muscular Dystrophy
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- #Duchenne--cTAP publishes research in PLOS ONE providing quantitative insights to assist the design and analysis of clinical trials in patients with Duchenne.cTAP Partner Wins ISPOR Award on Duchenne Muscular Dystrophy
CAMBRIDGE, Mass.--(BUSINESS WIRE)--#DMD--cTAP Partner Wins ISPOR Award on Duchenne Muscular DystrophycTAP to Present Late-breaking Results Supporting Advancements in Clinical Trial Design for Duchenne Muscular Dystrophy at the World Muscle Society Congress
CAMBRIDGE, Mass.--(BUSINESS WIRE)--#DMD--cTAP to Present Late-breaking Results Supporting Advancements in Clinical Trial Design for Duchenne Muscular Dystrophy at World Muscle Society
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Collaborative Trajectory Analysis Project
Sign Up For FreeTo access detailed company insights
cTAP focuses on enhancing clinical trials for Duchenne Muscular Dystrophy by leveraging data science to facilitate faster learning and smarter drug development. The organization aims to unlock the potential of patient data through strategic, collaborative, and non-competitive research, fostering cross-stakeholder collaboration. Their mission is to... Read More
